Comparison of gut microbiota in adult patients with type 2 diabetes and healthy individuals

被引:183
|
作者
Sedighi, Mansour [1 ]
Razavi, Shabnam [1 ,2 ]
Navab-Moghadam, Fatemeh [1 ]
Khamseh, Mohammad E. [3 ]
Alaei-Shahmiri, Fariba [4 ]
Mehrtash, Amirhosein [5 ]
Amirmozafari, Nour [1 ,2 ]
机构
[1] Iran Univ Med Sci, Sch Med, Dept Microbiol, Tehran 1439914153, Iran
[2] Iran Univ Med Sci, Microbial Biotechnol Res Ctr, Tehran, Iran
[3] Iran Univ Med Sci, Inst Endocrinol & Metab, Endocrine Res Ctr, Tehran, Iran
[4] Iran Univ Med Sci, Inst Endocrinol & Metab, Res Ctr Prevent Cardiovasc Dis, Tehran, Iran
[5] Pasteur Inst Iran, Biotechnol Res Ctr, Mol Med Dept, Tehran, Iran
关键词
Gut microbiota; Bacterial compositions; Type 2 diabetes mellitus; Metabolic syndrome; Real-time PCR; INTESTINAL MICROBIOTA; INSULIN-RESISTANCE; OBESITY; INFLAMMATION; BACTERIA; ASSOCIATION; RELIABILITY; METABOLISM; IMPACTS; ENERGY;
D O I
10.1016/j.micpath.2017.08.038
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Recent studies indicate that inflammatory reactions leading to the development of type 2 diabetes mellitus (T2DM) may also contribute to variations in the composition of the intestinal microbiota, suggesting a relation between T2DM and bacterial residents in the intestinal tract. This case-control study was designed to evaluate the composition of the gut microbiota dominant bacterial groups in patients with T2DM compared to the healthy people. A total of 36 adult subjects (18 patients diagnosed with T2DM and 18 healthy persons) were included in the study. The intestinal microbiota composition was investigated by quantitative real-time polymerase chain reaction (qPCR) method using bacterial 16S rRNA gene. The quantities of two groups of bacteria were meaningfully different among T2DM patients and healthy individuals. While, the level of Lactobacillus was significantly higher in the patients with T2DM (P value < 0.001), Bifidobacterium was significantly more frequent in the healthy people (P value < 0.001). The quantities of Prevotella (P value = 0.0.08) and Fusobacterium (P value = 0.99) genera in faecal samples were not significantly different between the two groups. The significant alterations in dominant faecal bacterial genera found in T2DM patients participating in the current study highlight the link between T2DM disease and compositional variation in intestinal flora. These findings may be valuable for developing approaches to control T2DM by modifying the gut microbiota. More investigations with focus on various taxonomic levels (family, genus and species) of bacteria are necessary to clarify the exact relevance of changes in the gut microbial communities with the progression of T2DM disorder. (C) 2017 Published by Elsevier Ltd.
引用
收藏
页码:362 / 369
页数:8
相关论文
共 50 条
  • [21] Variation of Carbohydrate-Active Enzyme Patterns in the Gut Microbiota of Italian Healthy Subjects and Type 2 Diabetes Patients
    Soverini, Matteo
    Turroni, Silvia
    Biagi, Elena
    Quercia, Sara
    Brigidi, Patrizia
    Candela, Marco
    Rampelli, Simone
    FRONTIERS IN MICROBIOLOGY, 2017, 8
  • [22] The Metabolic Functional Feature of Gut Microbiota in Mongolian Patients with Type 2 Diabetes
    Liu, Yanchao
    Pang, Hui
    Li, Na
    Jiao, Yang
    Zhang, Zexu
    Zhu, Qin
    JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 2024, 34 (06) : 1214 - 1221
  • [23] Transglucosidase Improves the Gut Microbiota Profile of Type 2 Diabetes Mellitus Patients
    Sasaki, Makoto
    Ogasawara, Naotaka
    Iida, Akihito
    Funaki, Yasushi
    Koikeda, Satoshi
    Kasugai, Kunio
    Joh, Takashi
    GASTROENTEROLOGY, 2013, 144 (05) : S563 - S564
  • [24] Gut Microbiota and Subclinical Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus
    Tsai, Hui-Ju
    Tsai, Wei-Chung
    Hung, Wei-Chun
    Hung, Wei-Wen
    Chang, Chen-Chia
    Dai, Chia-Yen
    Tsai, Yi-Chun
    NUTRIENTS, 2021, 13 (08)
  • [25] Gut microbiota and therapy for obesity and type 2 diabetes
    Zhang, Luyao
    Wang, Pai
    Huang, Juan
    Xing, Yanpeng
    Wong, F. Susan
    Suo, Jian
    Wen, Li
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [26] Gut microbiota and type 2 diabetes: Clinical insights
    Carmago, A.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2021, 51 : 17 - 17
  • [27] Gut Microbiota and Complications of Type-2 Diabetes
    Iatcu, Camelia Oana
    Steen, Aimee
    Covasa, Mihai
    NUTRIENTS, 2022, 14 (01)
  • [28] Characterization of Gut Microbiota in Lean Type 1 Diabetes, Overweight Type 1 Diabetes, and Healthy Controls
    Gowda, Shashikala B.
    Farrell, Ryan M.
    Macleish, Sarah A.
    Salem, Iman
    Retuerto, Mauricio A.
    Ghannoum, Mahmoud A.
    DIABETES, 2020, 69
  • [29] Role of gut microbiota in type 2 diabetes pathophysiology
    Gurung, Manoj
    Li, Zhipeng
    You, Hannah
    Rodrigues, Richard
    Jump, Donald B.
    Morgun, Andrey
    Shulzhenko, Natalia
    EBIOMEDICINE, 2020, 51
  • [30] Metformin induced changes in gut microbiome composition in healthy individuals and newly-diagnosed type 2 diabetes patients
    Elbere, I.
    Kalnina, I.
    Silamikelis, I.
    Dindune, I. I.
    Gulbinska, L.
    Zaharenko, L.
    Radovica-Spalvina, I.
    Gudra, D.
    Fridmanis, D.
    Konrade, I.
    Pirags, V.
    Klovins, J.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 85 - 86